Literature DB >> 12710521

Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes.

Bruce G Allen1, Luu Lien Phuong, Hala Farhat, Dominique Chevalier.   

Abstract

Endothelin-A (ET(A)) and endothelin-B (ET(B)) receptors have been demonstrated in intact heart and cardiac membranes. ET(A) receptors have been demonstrated on adult ventricular myocytes. The aim of the present study was to determine the presence of ET(B) and the relative contribution of this receptor subtype to total endothelin-1 (ET-1) binding on adult ventricular myocytes. Saturation binding experiments indicated that ET-1 bound to a single population of receptors (Kd = 0.52 +/- 0.13 nM, n = 4) with an apparent maximum binding (Bmax) of 2.10 +/- 0.25 sites (x 10(5))/cell (n = 4). Competition experiments using 40 pM [125I]ET-1 and nonradioactive ET-1 revealed a Ki of 660 +/- 71 pM (n = 10) and a Hill coefficient (nH) of 0.99 +/- 0.10 (n = 10). A selective ET(A) antagonist, BQ610, displaced 80% of the bound [125I]ET-1. No displacement was observed by concentrations of an ET(B)-selective antagonist, BQ788, up to 1.0 microM. However, in the presence of 1.0 microM BQ610, BQ788 inhibited the remaining [125I]ET-1 binding. Similarly, in the presence of 1.0 microM BQ788, BQ610 inhibited the remaining specific [125I]ET-1 binding. Binding of an ET(B1)-selective agonist, [125I]IRL-1620, confirmed the presence of ET(B). ET(B) bound to ET-1 irreversibly, whereas binding to ET(A) demonstrated both reversible and irreversible components, and BQ610 and BQ788 bound reversibly. Reducing the incubation temperature to 0 degrees C did not alter the irreversible component of ET-1 binding. Hence, both ET(A) and ET(B) receptors are present on intact adult rat ventricular myocytes, and the ratio of ET(A):ET(B) binding sites is 4:1. Both receptor subtypes bind to ET-1 by a two-step association involving the formation of a tight receptor-ligand complex; however, the kinetics of ET-1 binding to ET(A) versus ET(B) differ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710521     DOI: 10.1139/y02-155

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Differential endothelin receptor expression and function in rat myometrial cells and leiomyoma ELT3 cells.

Authors:  Marie-Noëlle Raymond; Philippe Robin; Federica De Zen; Ginette Vilain; Zahra Tanfin
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

2.  Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells.

Authors:  N Farhat; C C Matouk; A M Mamarbachi; P A Marsden; B G Allen; E Thorin
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

3.  Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes.

Authors:  Clémence Merlen; Nada Farhat; Xiaoyan Luo; David Chatenet; Artavazd Tadevosyan; Louis R Villeneuve; Marc-Antoine Gillis; Stanley Nattel; Eric Thorin; Alain Fournier; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-06-10       Impact factor: 5.000

Review 4.  The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.

Authors:  Faye M Drawnel; Caroline R Archer; H Llewelyn Roderick
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.